Rockefeller Capital Management
GOSS icon

Rockefeller Capital Management’s Gossamer Bio GOSS Stock Holding History

Rockefeller Capital Management’s Portfolio GOSS Stock Details GOSS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$15.6K Sell
1,320
-3
-0.2% -$39 ﹤0.01% 3982
2026
Q2 		$17.4K Sell
1,323
-22
-2% -$491 ﹤0.01% 3778
2026
Q1 		$35.4K Buy
1,345
+584
+77% +$73.4K ﹤0.01% 3447
2025
Q4 		$189K Buy
761
+633
+495% +$144K ﹤0.01% 2409
2025
Q3 		$26.8K Buy
+128
New +$22.6K ﹤0.01% 3204
2023
Q1 		– Hold
0
– – – 2763
2022
Q4 		– Hold
0
– – – 3995
2022
Q3 		– Hold
0
– – – 4068
2022
Q2 		– Hold
0
– – – 4216
2022
Q1 		– Hold
0
– – – 3947
2021
Q4 		– Hold
0
– – – 3850
2021
Q3 		– Hold
0
– – – 3739

Other funds holding GOSS

Context Capital Management
Context Capital Management Lajolla, California $4.89B AUM 1.86% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Worth Venture Partners
Worth Venture Partners Fort Lee, New Jersey $38.9M AUM 12.3% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
KCM
Kalehua Capital Management Dallas, Texas $132M AUM 92.09% 1-Year Est. Return
BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $114B AUM 35.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.23B AUM 121.47% 1-Year Est. Return
Squarepoint
Squarepoint New York $90.8B AUM 26.98% 1-Year Est. Return

Rockefeller Capital Management's GOSS Position: Q3 2026 in Review

Rockefeller Capital Management reduced its Gossamer Bio (GOSS) stake by 0.23% in Q3 2026, selling an estimated $39 and leaving 1,320 shares worth $15.6K. The position accounts for ﹤0.01% of the portfolio, ranked #3982.

Rockefeller Capital Management first reported a position in GOSS in Q3 2025 and has held it in 5 quarters since. The position peaked at $189K in Q4 2025. 50 funds tracked by Wall St. Rank hold GOSS as of Q3 2026.

  • Rockefeller Capital Management held 1,320 shares of Gossamer Bio worth $15.6K as of Q3 2026.
  • Rockefeller Capital Management sold 3 Gossamer Bio shares in Q3 2026, an estimated $39.
  • Gossamer Bio made up ﹤0.01% of Rockefeller Capital Management's portfolio in Q3 2026, its #3982 holding.
  • Rockefeller Capital Management first reported a position in Gossamer Bio in Q3 2025 and has held it in 5 quarters since.
  • Rockefeller Capital Management's Gossamer Bio position peaked at $189K in Q4 2025.
  • 50 funds tracked by Wall St. Rank held Gossamer Bio as of Q3 2026.

Based on Rockefeller Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.